Author Archive for Insider Scoop

55 Biggest Movers From Yesterday

Courtesy of Benzinga.

Gainers

  • Obalon Therapeutics, Inc. (NASDAQ: OBLN) shares jumped 233.3 percent to close at $1.30 on Wednesday after the company reported expanded data from a large scale commercial use study that was presented at the Digestive Disease Week.
  • Ascent Capital Group, Inc. (NASDAQ: ASCMA) shares jumped 51.4 percent to close at $1.37 after the company announced a restructuring support agreement with Monitronics International.
  • Valeritas Holdings, Inc. (NASDAQ: VLRX) shares dipped 26.3 percent to close at $2.78 following news added data from its VERDICT study was presented at the International Society for Pharmacoeconomics and Outcomes Research meeting.
  • Sea Limited (NYSE: SE) shares jumped 24.1 percent to close at $31.50 after the company reported Q1 sales results higher from last year.
  • Westwater Resources, Inc. (NASDAQ: WWR) shares gained 22.2 percent to close at $6.05.
  • Dyadic International, Inc. (NASDAQ: DYAI) gained 15.8 percent to close at $4.54.
  • Skyline Champion Corporation (NYSE: SKY) gained 13.9 percent to close at $24.80 following Q4 earnings.
  • Aurora Mobile Limited (NASDAQ: JG) rose 13.6 percent to close at $8.92.
  • Kodiak Sciences Inc. (NASDAQ: KOD) climbed 12.5 percent to close at $10.24.
  • Co-Diagnostics, Inc. (NASDAQ: CODX) gained 12.3 percent to close at $1.03 after the company announced US sales of Vector Control Laboratory Packages and Tests.
  • Ruhnn Holding Limited (NASDAQ: RUHN) surged 11.1 percent to close at $4.00.
  • Veritone, Inc. (NASDAQ: VERI) shares gained 11 percent to close at $9.56.
  • DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) rose 10.7 percent to close at $2.79.
  • Karyopharm Therapeutics Inc. (NASDAQ: KPTI) jumped 10.7 percent to close at $5.79.
  • Spherix Incorporated (NASDAQ: SPEX) rose 9.8 percent to close at $3.14.
  • Avon Products, Inc. (NYSE: AVP) gained 9.1 percent to close at $3.49 after the company confirmed its in advanced talks with Brazil’s Natura for an all-stock takeover.
  • CSW Industrials, Inc. (NASDAQ: CSWI) surged 9 percent to close at $64.90 following Q4 earnings.
  • Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) gained 8.9 percent to close at $4.02.
  • Clean Energy Fuels Corp. (NASDAQ: CLNE) jumped 7.9 percent to close at $3.00 after the company announced


continue reading





25 Stocks Moving In Thursday’s Pre-Market Session

Courtesy of Benzinga.

Gainers

  • Neovasc Inc (NASDAQ: NVCN) shares rose 98 percent to $0.93 in pre-market trading following news 2-year follow-up safety and efficacy data for its Neovasc Reducer was published in the International Journal of Cardiology.
  • Avon Products, Inc. (NYSE: AVP) shares rose 15.8 percent to $4.04 in pre-market trading after Natura reported it has reached a deal to buy Avon. The companies’ joint annual sales will exceed $10 billion.
  • Netshoes (Cayman) Limited (NASDAQ: NETS) rose 12.2 percent to $2.20 in pre-market trading.
  • L Brands, Inc. (NYSE: LB) shares rose 12 percent to $24.08 in pre-market trading after the company reported better-than-expected Q1 sales results. The company also raised the low end of FY19 EPS guidance.
  • Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) rose 8.2 percent to $17.99 in pre-market trading following news of breakthrough therapy designation for LN-145 for the treatment of advanced cervical cancer patients who have progressed on or after chemo.
  • Inseego Corp. (NASDAQ: INSG) shares rose 6.3 percent to $5.79 in pre-market trading after gaining 5.83 percent on Wednesday.
  • Bridgeline Digital, Inc. (NASDAQ: BLIN) rose 4.6 percent to $5.19 in pre-market trading after declining 4.62 percent on Wednesday.
  • BJs Wholesale Club Holdings Inc (NYSE: BJ) rose 4.3 percent to $26.50 in pre-market trading after the company reported better-than-expected earnings for its first quarter.
  • Copart, Inc. (NASDAQ: CPRT) rose 3.4 percent to $67.00 in pre-market trading after reporting better-than-expected results for its third quarter.
  • Fastenal Company (NASDAQ: FAST) rose 3.1 percent to $33.12 in pre-market trading.
  • Best Buy Co Inc (NYSE: BBY) rose 2.7 percent to $71.01 in pre-market trading after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 EPS and sales guidance above the analyst estimates.
  • Medtronic PLC (NYSE: MDT) rose 2 percent to $90.50 in pre-market trading after reporting upbeat earnings for its fourth quarter.

Find out what’s going on in today’s market and bring any questions you have to Benzinga’s PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Outlook Therapeutics, Inc. (NASDAQ: OTLK) fell 11.5 percent to $2.24 in pre-market trading after dipping 18.39 percent


continue reading





50 Biggest Movers From Yesterday

Courtesy of Benzinga.

Gainers

  • JMU Ltd- ADR (NASDAQ: JMU) shares jumped 61.2 percent to close at $1.95 after the company acquired Unicorn Investment Limited.
  • CIRCOR International, Inc. (NYSE: CIR) shares surged 40.3 percent to close at $43.00 on Tuesday after Crane Co. (NYSE: CR) reported a $45 per share cash bid for CIRCOR.
  • Westwater Resources, Inc. (NASDAQ: WWR) shares rose 29.9 percent to close at $4.95.
  • Dycom Industries, Inc. (NYSE: DY) shares gained 25.3 percent to close at $57.05 after reporting upbeat Q1 results.
  • Array BioPharma Inc. (NASDAQ: ARRY) jumped 23 percent to close at $25.77 after the company reported BRAFTOVE + MEKTOVI + Cetiximab met primary endpoints.
  • DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) gained 21.7 percent to close at $2.52.
  • Red Violet, Inc. (NASDAQ: RDVT) gained 20.4 percent to close at $12.21.
  • Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) climbed 19.2 percent to close at $5.40.
  • Kaixin Auto Holdings (NASDAQ: KXIN) rose 15.9 percent to close at $3.20.
  • Qudian Inc. (NYSE: QD) climbed 15.5 percent to close at $7.09.
  • Daqo New Energy Corp. (NYSE: DQ) rose 15.2 percent to close at $35.88 after reporting Q1 results.
  • USA Technologies, Inc. (NASDAQ: USAT) shares surged 14.6 percent to close at $6.76 after Hudson Executive Capital disclosed a new 12 percent stake in the company.
  • Jumia Technologies AG (NYSE: JMIA) shares gained 13.9 percent to close at $23.29.
  • Overstock.com, Inc. (NASDAQ: OSTK) gained 13 percent to close at $11.19.
  • Payment Data Systems, Inc. (NASDAQ: PYDS) climbed 12.9 percent to close at $2.37 after reporting a partnership with Pineapple Payments.
  • Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) rose 12.7 percent to close at $21.35. Arrowhead Pharmaceuticals will replace The Navigators Group in the the S&P SmallCap 600.
  • Sesen Bio Inc (NASDAQ: SESN) shares gained 12.6 percent to close at $1.97 after the company reported acceptance of analytical comparability plan by the FDA to support the BLA and commercialization of Vicinium.
  • Coda Octopus Group, Inc. (NASDAQ: CODA) rose 12.4 percent to close at $14.39.
  • PPDAI Group Inc. (NYSE: PPDF) surged 12.4 percent


continue reading





A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Fed Minutes

Courtesy of Benzinga.

A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Fed Minutes

Pre-open movers

U.S. stock futures traded slightly lower in early pre-market trade. The Federal Open Market Committee will issue minutes of its meeting at 2:00 p.m. ET. New York Federal Reserve Bank President John Williams will speak in New York at 10:00 a.m. ET, while Atlanta Federal Reserve Bank President Raphael Bostic is set to speak in Dallas, TX at 10:10 a.m. ET. Dallas Federal Reserve Bank President Robert Kaplan is set to speak in Dallas, TX at 10:15 a.m. ET, while Atlanta Federal Reserve Bank President Raphael Bostic will speak in Dallas, TX at 4:00 p.m. ET.

Futures for the Dow Jones Industrial Average dipped 25 points to 25,850.00, while the Standard & Poor’s 500 index futures fell 4.6 points to 2,861.50. Futures for the Nasdaq 100 index fell 23 points to 7,441.00.

Oil prices traded lower as Brent crude futures fell 0.4 percent to trade at $71.88 per barrel, while US WTI crude futures fell 0.8 percent to trade at $62.61 a barrel. The Energy Information Administration’s weekly report on petroleum inventories in the U.S. will be released at 10:30 a.m. ET.

A Peek Into Global Markets

European markets were higher today, with the Spanish Ibex Index rising 0.3 percent, STOXX Europe 600 Index climbed 0.1 percent and German DAX 30 index gained 0.3 percent. The UK’s FTSE index was trading higher by 0.4 percent, while French CAC 40 Index rose 0.1 percent.

In Asian markets, Japan’s Nikkei Stock Average rose 0.05 percent, Hong Kong’s Hang Seng Index climbed 0.18 percent, China’s Shanghai Composite Index fell 0.49 percent and India’s BSE Sensex gained 0.36 percent.

Broker Recommendation

Analysts at Stephens & Co. downgraded Activision Blizzard, Inc. (NASDAQ: ATVI) from Overweight to Equal-Weight and lowered the price target from $57 to $52.

Activision Blizzard shares fell 1.4 percent to $42.86 in pre-market trading.

Breaking News

  • Nordstrom, Inc. (NYSE: JWN) reported weaker-than-expected earnings for its first quarter and cut FY2019 guidance.
  • VF Corp (NYSE: VFC) reported upbeat earnings for its fourth quarter.
  • Toll Brothers Inc (NYSE: TOL) reported better-than-expected results for its second quarter, but issued weak 2019 home sales forecast.
  • Urban Outfitters, Inc. (NASDAQ: URBN) reported upbeat earnings for its first quarter. Comps were up 1 percent in the quarter.

Posted-In: A Peek Into The Markets US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets





Amgen To Buy Danish Collaborator Nuevolution For $167M

Courtesy of Benzinga.

Amgen To Buy Danish Collaborator Nuevolution For $167M

Amgen, Inc. (NASDAQ: AMGN) took a logical step forward in buying a preclinical biotech it has been collaborating with since 2016. 

What Happened

Amgen announced Wednesday an agreement to buy Copenhagen-based Nuevolution for $167 million.

The U.S. company announced a recommended public cash offer to Nuevolution shareholders to tender their shares for 32.5 Swedish kronas ($3.37) each in cash.

The offer represents a 169-percent premium over Nuevolution’s Tuesday closing price. 

Nuevolution’s shares are listed on the Nasdaq Stockholm exchange.

The target company’s board has unanimously recommended Amgen’s cash tender offer to its shareholders.

Institutional investors that own a combined 59 percent of the total number of shares and votes in Nuevolution have given their commitment to subscribe to the tender offer, subject to certain conditions, Amgen said. 

Amgen said it will fully finance the deal with cash on hand.

Why It’s Important

Nuevolution is a small-molecule drug discovery platform biotech that has partnerships with pharma and biotech companies, with its internal programs focusing on inflammation, oncology and immuno-oncology.

Its proprietary Chemtics platform provides access to screening billions of molecules and efficient optimization of drug properties to identify drug candidates.

Amgen and Nuevolution have had an ongoing multitarget collaboration partnership since October 2016. Amgen said it’s exercised its contractual opt-in right for the first two cancer programs under this partnership.

“A business combination of Amgen and Nuevolution will enable a closer integration of Nuevolution’s technology and drug discovery expertise with Amgen’s experience and capabilities in research and development, manufacturing and commercialization,” the Thousand Oaks, California-based company said in a press release. 

What’s Next

If Amgen succeeds in buying out more than 90 percent of Nuevolution shares, the company said it will initiate a compulsory acquisition procedure to buy out the remaining shares under the Swedish Companies Act.

Amgen shares were down 0.28 percent at $169.21 at the time of publication Wednesday. 

Related Links:

5 ASCO Abstracts That Moved Stocks

The Daily Biotech Pulse: Tocagen Tumbles, OncoSec Offering, Novartis Asthma Combo Drug Study


Photo by Coolcaesar/Wikimedia.  

Posted-In: NuevolutionBiotech News M&A Trading Ideas General Best of Benzinga





Ericsson Could Benefit From 5G Deployment, US Pressure On Huawei, BofA Says In Upgrade

Courtesy of Benzinga.

Ericsson Could Benefit From 5G Deployment, US Pressure On Huawei, BofA Says In Upgrade

Bank of America Merrill Lynch held meetings with Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) management Friday that it said inspired greater confidence in the company’s scope for growth and turnaround efforts.

The Analyst

Tal Liani upgraded Ericsson from Neutral to Buy and raised the price target from $10.40 to $11.40.

The Thesis

BofA’s main takeaways from the management meetings in Sweden are positive, Liani said in the Wednesday upgrade note. (See his track record here.)

The company’s execution remains strong at a critical time when 5G decisions are being made, the analyst said. At this time, margins are being supported by a refined product portfolio and technical leadership, he said. 

Although growth in China could put some pressure on margins, Ericsson’s product leadership and low total cost of ownership may offset the impact, allowing the company to gain market share without significant margin contraction, Liani said. 

Ericsson’s 5G performance may be helped by two competitive forces going forward, the analyst said. 

First, the U.S. pressure on Huawei may be positive for Ericsson, given that Huawei is Ericsson’s top competitor, he said. 

Second, a potential merger between T-Mobile Us Inc (NASDAQ: TMUS) and Sprint Corp (NYSE: S) could accelerate 5G deployment. This could also trigger increased spectrum investments at AT&T Inc. (NYSE: T) and Verizon Communications Inc. (NYSE: VZ), Liani said. 

“We expect competition and spectrum availability to drive 5G deployments in other parts of the world, translating into a prolonged cycle, which is currently at its very early innings.” 

BofA sees potential upside to the Street’s 2020 estimates for Ericsson. 

Price Action

Ericsson shares were trading up 3.92 percent at $10.08 at the time of publication Wednesday. 

Related Links:

Benzinga’s Top Upgrades, Downgrades For May 22, 2019

64 Biggest Movers From Yesterday

Latest Ratings for ERIC

Date Firm Action From To
May 2019 Upgrades Neutral Buy
Dec 2018 Upgrades Underperform Market Perform
Sep 2018 Maintains Hold Hold

View More Analyst Ratings for ERIC


View the Latest Analyst Ratings

Posted-In: 5G Bank of America Merrill Lynch Huawei Tal LianiAnalyst Color Upgrades Price Target Analyst Ratings Best of Benzinga





Morgan Stanley Lowers Tesla Bear-Case Scenario Price Target To $10, Highlights Slowing Demand

Courtesy of Benzinga.

Morgan Stanley Lowers Tesla Bear-Case Scenario Price Target To $10, Highlights Slowing Demand

Tesla Inc (NASDAQ: TSLA) shares dropped back below $200 on Tuesday after a high-profile Wall Street analyst cut his bear-case price target for Tesla by nearly 90 percent.

The Analyst

Morgan Stanley analyst Adam Jonas reiterated his Equal-Weight rating and $230 price target for Tesla, but cut his bear-case price target from $97 to just $10.

Jonas’ commentary comes just a day after Wedbush lowered its price target for Tesla from 275 to $230.

The Thesis

Jonas said his bear-case scenario involves Tesla failing to drum up demand in China.

“Our revised bear case assumes Tesla misses our current Chinese volume forecast by roughly half to account for the highly volatile trade situation in the region,particularly around areas of technology, which we believe run a high and increasing risk of government/regulatory attention,” Jonas wrote in a note.

Morgan Stanley is currently forecasting average annual China demand of 165,000 vehicles from 2020 through 2024.

Jonas said Tesla’s recent $2.7 billion capital raise has eliminated near-term liquidity issues for at least another year, but slowing demand growth has hindered the company’s ability to self-fund via cash flow.

With Tesla stock essentially flat over the past five years compared to a more than 50 percent gain for the S&P 500, Jonas said the company may be approaching a point where the low stock price in itself is having a negative impact on company morale and investor sentiment.

Jonas said one of the primary concerns for Tesla investors is that the company may have saturated the U.S. electric vehicle market, limiting its potential opportunities for growth. He said Tesla may have simply outgrown the market for EVs at this point, limiting the business’ ability to expand.

Jonas said Tesla may need to pursue the Chinese domestic market, the lower-priced SUV niche and/or logistics/mobility fleets to drive near-term demand.

Price Action

Tesla traded lower by 3 percent on Tuesday to $199.50 per share and is now down 42 percent in the past six months.

Related Links:

Short Sellers Making Bank Following Tesla’s Technical Breakdown

Wedbush Lowers Tesla Price Target, Shares Fall Below $200

Latest Ratings for TSLA

Date Firm Action From To
May


continue reading





Off-Roaders Are In Buying Mood, BMO Says In Polaris Upgrade

Courtesy of Benzinga.

Off-Roaders Are In Buying Mood, BMO Says In Polaris Upgrade

A long winter and the worst of the U.S.-China trade war may both be in the rearview mirror for off-road vehicle maker Polaris Industries Inc. (NYSE: PII), BMO Capital Markets said Tuesday.

The Analyst

Gerrick Johnson upgraded Polaris from Market Perform to Outperform with price target lifted from $96 to $99.

The Thesis

The worst-case scenario on tariffs is now accounted for in Polaris’ share price, Johnson said in a Tuesday note. (See his track record here.)

From now on, there’s a higher likelihood of tariffs being reduced than increased, the analyst said. 

With better weather, now is the time when customers are in the market for off-road vehicles, Johnson said. And that makes it a good time to be in the market for Polaris stock, he said. 

“Despite a volatile stock market and macro uncertainty, PII’s customers remain optimistic and we are seeing improvements in (off-road vehicle) demand as the spring weather has improved.” 

An anticipated major product upgrade announcement by Polaris this summer is “the worst-kept secret in powersports,” the analyst said. 

Price Action

Polaris shares were trading up 3.9 percent at $89.28 at the time of publication Tuesday. 

Related Links:

Polaris Has Favorable Risk-Reward, KeyBanc Says In Upgrade

China Will Raise Tariffs On $60B Worth Of US Goods To 25% By June 1

Photo courtesy of Polaris. 

Latest Ratings for PII

Date Firm Action From To
May 2019 Upgrades Market Perform Outperform
May 2019 Maintains Buy
May 2019 Upgrades Neutral Outperform

View More Analyst Ratings for PII


View the Latest Analyst Ratings

Posted-In: BMO Capital Markets Gerrick JohnsonAnalyst Color Upgrades Price Target Analyst Ratings Best of Benzinga





60 Biggest Movers From Friday

Courtesy of Benzinga.

Gainers

  • Fastly, Inc. (NYSE: FSLY) shares jumped 50 percent to close at $23.99 on Friday. Fastly priced its 11.25 million share IPO at $16 per share.
  • Outlook Therapeutics, Inc. (NASDAQ: OTLK) shares climbed 37.3 percent to close at $2.10 on Friday after the stock rose over 68 percent Thursday following an Oppenheimer initiation at Outperform with a price target of $12.
  • Cray Inc. (NASDAQ: CRAY) shares rose 22.5 percent to close at $36.52 after Hewlett Packard Enterprise Co (NYSE: HPE) announced plans to acquire Cray in a transaction valued at approximately $1.3 billion.
  • Luckin Coffee Inc. (NASDAQ: LK) shares rose 19.9 percent to close at $20.38 after pricing its IPO at $17 per share.
  • B.O.S Better Online Solutions Ltd. (NASDAQ: BOSC) rose 16.3 percent to close at $3.00.
  • RAVE Restaurant Group, Inc. (NASDAQ: RAVE) gained 15.3 percent to close at $2.64.
  • Salem Media Group, Inc. (NASDAQ: SALM) climbed 15.2 percent to close at $2.39.
  • CAE Inc. (NYSE: CAE) shares rose 14.6 percent to close at $27.25 as the company reported upbeat Q4 results.
  • Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) gained 13.7 percent to close at $11.26 after Sarissa Capital raised its stake in the company from 7.54 million shares to 9.49 million shares.
  • 21Vianet Group, Inc. (NASDAQ: VNET) rose 13.5 percent to close at $8.99 r after the company reported better-than-expected Q1 EPS and sales results.
  • Palomar Holdings, Inc. (NASDAQ: PLMR) climbed 12.8 percent to close at $22.30.
  • Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 11.6 percent to close at $5.60.
  • Adverum Biotechnologies, Inc. (NASDAQ: ADVM) gained 11.3 percent to close at $9.05.
  • SSLJ.com Limited (NASDAQ: SSLJ) shares rose 11.1 percent to close at $3.80.
  • Globus Maritime Limited (NASDAQ: GLBS) gained 11.1 percent to close at $3.30.
  • Armstrong Flooring, Inc. (NYSE: AFI) shares gained 9.5 percent to close at $11.52 after the company reported commencement of tender offer for up to $50 million in common stock.
  • Urovant Sciences Ltd. (NASDAQ: UROV) shares climbed 9.5 percent to close at $7.39.
  • The Lovesac Company (NASDAQ: LOVE) gained 8.9 percent


continue reading





Morgan Stanley Upgrades Target After Recent Pullback

Courtesy of Benzinga.

Morgan Stanley Upgrades Target After Recent Pullback

Target Corporation (NYSE: TGT)’s recent pullback is more on the mark for Morgan Stanley, which upgraded the stock.

The Analyst

Morgan Stanley’s Simeon Gutman upgraded Target from Underweight to Equal-weight with a $67 price target.

The Thesis

Morgan Stanley sees less downside following a drop of about 15 percent in the value of Target’s stock.

“We still have concerns around TGT’s medium-term margins, but they seem to be reflected in the stock’s below-average valuation and risk/reward now looks more balanced,” Gutman wrote in a Monday note to investors.

The stock had run up in the last couple of years, but pulled back in the past month.

Gutman also likes Target’s emerging story as a retail “survivor,” along with a few other retail giants, as other smaller operations struggle to compete amid the shift to online buying. Target has made investments to promote traffic in-store and online and reduce costs and its top-line growth has been reinvigorated.

Price Action

Target’s stock traded up 1 percent at $711.54 per share on Monday morning.

Related Links:

The Street Reacts To Target’s Q4 Earnings, Analyst Day

What To Make Of A Messy First Quarter For US Retailers

Photo by Mike Kalasnik/Wikimedia.

Latest Ratings for TGT

Date Firm Action From To
May 2019 Upgrades Underweight Equal-Weight
May 2019 Downgrades Outperform Market Perform
Apr 2019 Upgrades Equal-Weight Overweight

View More Analyst Ratings for TGT


View the Latest Analyst Ratings

Posted-In: Morgan Stanley Simeon Gutman Target Corp. US retailersAnalyst Color Upgrades Top Stories Analyst Ratings Best of Benzinga





 
 
 

Phil's Favorites

Getting ready for hurricane season: 4 essential reads

 

Getting ready for hurricane season: 4 essential reads

Debris in a boatyard in Mexico Beach, Fla., on Oct. 11, 2018, after Hurricane Michael heavily damaged the town. AP Photo/Gerald Herbert, File

Courtesy of Jennifer Weeks, The Conversation

The official Atlantic hurricane season begins on June 1, even as many communities are still recovering from a destructive year in 2018. Hurricane Florence swamped much of the Carolinas in September, followed by Hurricane Michael, which battered ...



more from Ilene

Zero Hedge

USPS Starts Testing Self-Driving Trucks For Long Hauls

Courtesy of ZeroHedge. View original post here.

The US Postal Service (USPS) has awarded TuSimple, a global self-driving truck company, a contract to haul mail across the country with self-driving trucks, a move that could save the money-losing government agency millions of dollars per year if implemented, reported a TuSimple press release.

The two-week pilot started Tuesday will haul USPS trailers about 1,000 miles bet...



more from Tyler

Kimble Charting Solutions

DAX (Germany) About To Send A Bearish Message To The S&P 500?

Courtesy of Chris Kimble.

Is the DAX index from Germany about to send a bearish message to stocks in Europe and the States? Sure could!

This chart looks at the DAX over the past 9-years. It’s spent the majority of the past 8-years inside of rising channel (1), creating a series of higher lows and higher highs.

It looks to have created a “Double Top” as it was kissing the underside of the rising channel last year at (2).

After creating the potential double top, the DAX index has continued to create a series of lower highs, while experiencing a bearish divergence with the S...



more from Kimble C.S.

Insider Scoop

55 Biggest Movers From Yesterday

Courtesy of Benzinga.

Gainers
  • Obalon Therapeutics, Inc. (NASDAQ: OBLN) shares jumped 233.3 percent to close at $1.30 on Wednesday after the company reported expanded data from a large scale commercial use study that was presented at the Digestive Disease Week.
  • Ascent Capital Group, Inc. (NASDAQ: ASCMA) shares jumped 51.4 percent to close at $1.37 after the company announced a restructuring support agreement with Monitronics International.
  • Valeritas Holdings, Inc. (NASDAQ: VLRX) shares dippe...


http://www.insidercow.com/ more from Insider

Chart School

Weekly Market Recap May 18, 2019

Courtesy of Blain.

China – U.S. trade talk continued to dominate the week.   A heavy selloff Monday was followed by 3 up days, with Friday moderately down.

On Monday, Chinese officials announced retaliatory tariffs against the U.S., hitting $60 billion in annual exports to China with new or expanded duties that could reach 25%.

Then on Wednesday:

The Trump administration plans to delay a decision on instituting new tariffs on car and auto part imports for up to six months, according to media reports.

...

more from Chart School

Digital Currencies

Cryptocurrencies are finally going mainstream - the battle is on to bring them under global control

 

Cryptocurrencies are finally going mainstream – the battle is on to bring them under global control

The high seas are getting lower. dianemeise

Courtesy of Iwa Salami, University of East London

The 21st-century revolutionaries who have dominated cryptocurrencies are having to move over. Mainstream financial institutions are adopting these assets and the blockchain technology that enables them, in what ...



more from Bitcoin

Biotech

DNA as you've never seen it before, thanks to a new nanotechnology imaging method

Reminder: We are available to chat with Members, comments are found below each post.

 

DNA as you've never seen it before, thanks to a new nanotechnology imaging method

A map of DNA with the double helix colored blue, the landmarks in green, and the start points for copying the molecule in red. David Gilbert/Kyle Klein, CC BY-ND

Courtesy of David M. Gilbert, Florida State University

...



more from Biotech

ValueWalk

More Examples Of "Typical Tesla "wise-guy scamminess"

By Jacob Wolinsky. Originally published at ValueWalk.

Stanphyl Capital’s letter to investors for the month of March 2019.

rawpixel / Pixabay

Friends and Fellow Investors:

For March 2019 the fund was up approximately 5.5% net of all fees and expenses. By way of comparison, the S&P 500 was up approximately 1.9% while the Russell 2000 was down approximately 2.1%. Year-to-date 2019 the fund is up approximately 12.8% while the S&P 500 is up approximately 13.6% and the ...



more from ValueWalk

Members' Corner

Despacito - How to Make Money the Old-Fashioned Way - SLOWLY!

Are you ready to retire?  

For most people, the purpose of investing is to build up enough wealth to allow you to retire.  In general, that's usually enough money to reliably generate a year's worth of your average income, each year into your retirement so that that, plus you Social Security, should be enough to pay your bills without having to draw down on your principle.

Unfortunately, as the last decade has shown us, we can't count on bonds to pay us more than 3% and the average return from the stock market over the past 20 years has been erratic - to say the least - with 4 negative years (2000, 2001, 2002 and 2008) and 14 positives, though mostly in the 10% range on the positives.  A string of losses like we had from 2000-02 could easily wipe out a decades worth of gains.

Still, the stock market has been better over the last 10 (7%) an...



more from Our Members

Mapping The Market

It's Not Capitalism, it's Crony Capitalism

A good start from :

It's Not Capitalism, it's Crony Capitalism

Excerpt:

The threat to America is this: we have abandoned our core philosophy. Our first principle of this nation as a meritocracy, a free-market economy, where competition drives economic decision-making. In its place, we have allowed a malignancy to fester, a virulent pus-filled bastardized form of economics so corrosive in nature, so dangerously pestilent, that it presents an extinction-level threat to America – both the actual nation and the “idea” of America.

This all-encompassing mutant corruption saps men’s souls, crushes opportunities, and destroys economic mobility. Its a Smash & Grab system of ill-gotten re...



more from M.T.M.

OpTrader

Swing trading portfolio - week of September 11th, 2017

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Promotions

Free eBook - "My Top Strategies for 2017"

 

 

Here's a free ebook for you to check out! 

Phil has a chapter in a newly-released eBook that we think you’ll enjoy.

In My Top Strategies for 2017, Phil's chapter is Secret Santa’s Inflation Hedges for 2017.

This chapter isn’t about risk or leverage. Phil present a few smart, practical ideas you can use as a hedge against inflation as well as hedging strategies designed to assist you in staying ahead of the markets.

Some other great content in this free eBook includes:

 

·       How 2017 Will Affect Oil, the US Dollar and the European Union

...

more from Promotions





About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>